Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01773096 · ClinicalTrials.gov registry record · Phase 4
Methylnaltrexone Use for Opioid-induced Postoperative Constipation
A Phase 4 study, sponsored by Shriners Hospitals for Children.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT01773096 is a Phase 4 study that has completed, run by Shriners Hospitals for Children. The registered enrollment target is 60 participants.
The verdict
NCT01773096, a Phase 4 study, has completed, sponsored by Shriners Hospitals for Children.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the routine use of methylnaltrexone in the post-operative pediatric spinal fusion patient will decrease the incidence of constipation.
Interventions
- DRUG Methylnaltrexone
- DRUG Senna, docusate sodium, bisacodyl, magnesium hydroxide, Miralax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2013-05 |
| Est. Completion | 2015-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01773096
The ClinicalTrials.gov registry entry for NCT01773096 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shriners Hospitals for Children, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Methylnaltrexone is the first listed.
NCT01773096 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01773096 about?
NCT01773096 is a clinical study titled "Methylnaltrexone Use for Opioid-induced Postoperative Constipation". The purpose of this study is to determine whether the routine use of methylnaltrexone in the post-operative pediatric spinal fusion patient will decrease the incidence of constipation.
What is the current status of trial NCT01773096?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2013-05. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01773096?
The interventions under investigation include: Methylnaltrexone (DRUG), Senna, docusate sodium, bisacodyl, magnesium hydroxide, Miralax (DRUG).
Who is sponsoring clinical trial NCT01773096?
This trial is sponsored by Shriners Hospitals for Children, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.